AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 294: F236-F244, 2008. First published October 31, 2007; doi:10.1152/ajprenal.00331.2007
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/F236    most recent
00331.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, S.-Y.
Right arrow Articles by O, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, S.-Y.
Right arrow Articles by O, K.

Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-{kappa}B activation

Sun-Young Hwang,1,3,* Connie W. H. Woo,2,3,* Kathy K. W. Au-Yeung,3 Yaw L. Siow,2,3,4 Tong Y. Zhu,3 and Karmin O1,2,3

1Department of Animal Science and 2Department of Physiology, University of Manitoba, Winnipeg; 3Canadian Center for Agri-Food Research in Health and Medicine, St. Boniface Hospital Research Center, Winnipeg; and 4Center for Research and Treatment of Atherosclerosis, University of Manitoba, Winnipeg, Manitoba, Canada

Submitted 16 July 2007 ; accepted in final form 22 October 2007

Hyperhomocysteinemia, or an elevation of blood homocysteine (Hcy) levels, is associated with cardiovascular disorders. Although kidney dysfunction is an important risk factor causing hyperhomocysteinemia, the direct effect of Hcy on the kidney is not well documented. There is a positive association between an elevation of blood Hcy levels and the development of chronic kidney disease. Inflammatory response such as increased chemokine expression has been implicated as one of the mechanisms for renal disease. Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine that is involved in the inflammatory response in renal disease. Nuclear factor-{kappa}B (NF-{kappa}B) plays an important role in upregulation of MCP-1 expression. We investigated the effect of hyperhomocysteinemia on MCP-1 expression and the molecular mechanism underling such an effect in rat kidneys as well as in proximal tubular cells. Hyperhomocysteinemia was induced in rats fed a high-methionine diet for 12 wk. The MCP-1 mRNA expression and MCP-1 protein levels were significantly increased in kidneys isolated from hyperhomocysteinemic rats. The NF-{kappa}B activity was significantly increased in the same kidneys. Pretreatment of hyperhomocysteinemic rats with a NF-{kappa}B inhibitor abolished hyperhomocysteinemia-induced MCP-1 expression in the kidney. To confirm the causative role of NF-{kappa}B activation in MCP-1 expression, human kidney proximal tubular cells were transfected with decoy NF-{kappa}B oligodeoxynucleotide to inhibit NF-{kappa}B activation. Such a treatment prevented Hcy-induced MCP-1 mRNA expression in tubular cells. Our results suggest that hyperhomocysteinemia stimulates MCP-1 expression in the kidney via NF-{kappa}B activation. Such an inflammatory response may contribute to renal injury associated with hyperhomocysteinemia.

hyperhomocysteinemia



Address for reprint requests and other correspondence: K. O, Integrative Biology Laboratory, St. Boniface Hospital Research Center, 351 Tache Ave., Winnipeg, Manitoba, Canada R2H 2A6 (e-mail: karmino{at}sbrc.ca)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. Wu, Y. L. Siow, and K. O
Induction of hepatic cyclooxygenase-2 by hyperhomocysteinemia via nuclear factor-{kappa}B activation
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1086 - R1094.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.